JAZZ PHARMACEUT. DL-,0001
JAZZ PHARMACEUT. DL-,0001/ IE00B4Q5ZN47 /
J7Z
|
2024-09-20 9:55:01 PM
|
Chg.
-0.7400
|
Volume |
Bid9:59:59 PM |
Ask9:59:52 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
98.5000EUR
|
-0.75%
|
0
Turnover: 0.0000 |
-Bid Size: - |
-Ask Size: - |
6.13 bill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
6.55 USD |
- |
| EPS Diluted: |
6.10 USD |
- |
| Revenues per Share: |
61.50 USD |
6.43% |
| Book Value per Share: |
59.94 USD |
23.02% |
| Cash Flow per Share: |
17.52 USD |
-12.79% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
3,834.20 USD |
4.78% |
| Net Income: |
414.83 USD |
- |
| Operating Cash Flow: |
1,092.01 USD |
- |
| Cash and Cash Equivalents: |
1,506.31 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
16.91 |
18.78 |
| P/S Ratio: |
1.80 |
2.00 |
| P/BV ratio: |
1.85 |
2.05 |
| P/CF Ratio: |
6.32 |
7.02 |
| PEG: |
- |
- |
| Earnings Yield: |
5.91% |
5.33% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
6.13 bill. EUR |
6.95 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
61.75 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
15.09% |
| Net Profit Margin: |
10.82% |
| Return on Equity: |
11.10% |
| Return on Assets: |
3.64% |
Financial Strength
| Liquidity I / Cash Ratio: |
98.02% |
| Liquidity II / Quick Ratio: |
143.95% |
| Liquidity III / Current Ratio: |
223.56% |
| Debt / Equity Ratio: |
204.88% |
| Dynam. Debt / Equity Ratio: |
701.13% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
